Potential Use of Recombinant Human Thyrotropin in the Treatment of Distant Metastases in Patients with Differentiated Thyroid Cancer
- 1 January 2013
- journal article
- review article
- Published by Elsevier in Endocrine Practice
- Vol. 19 (1) , 139-148
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSHThe Journal of Clinical Endocrinology & Metabolism, 2011
- Sudden onset of haemoptysis and hypoxia after recombinant human thyroid-stimulating hormone use in a patient with papillary thyroid carcinoma and pulmonary metastasesInternal Medicine Journal, 2009
- Recombinant Human Thyrotropin Reduces Endothelium-Dependent Vasodilation in Patients Monitored for Differentiated Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2006
- Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patientsClinical Endocrinology, 2006
- Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.2006
- Influence of Human Body Composition on Serum Peak Thyrotropin (TSH) after Recombinant Human TSH Administration in Patients with Differentiated Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2005
- Near-Lethal Respiratory Failure After Recombinant Human Thyroid-Stimulating Hormone Use in a Patient with Metastatic Thyroid CarcinomaThyroid®, 2003
- Value of recombinant human thyrotropin in high-dose radioiodine therapy: a case report.2002
- Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSHEuropean Journal of Endocrinology, 2001
- Papillary Thyroid Carcinoma Metastatic to the Pituitary GlandThyroid®, 1999